SciSight Ecosystem
WoS SCIE Q1SCImago #31,883CAS 4区Subscription

European Review for Medical and Pharmacological Sciences

Abbreviation (ISO):EUR. REV. MED. PHARMACOL. SCI
Country: Italy•WoS SCIE Quartile: Q1•SCImago Rank: #31,883•Identifier (ISSN):1128-3602(Print)/2284-0729(Online)•Articles / Year: 843•Estimated Publication Fee (APC): $3,052 USD
Clarivate Impact Factor (IF 2024)Q1
N/A

Leading citation impact metric from Clarivate Journal Citation Reports

H-Index (2021)
48

48 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessSubscription
843articles/year
0% Gold OA•86.94% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q4

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20251.00đ
WoS Q4
🔵 Computed
20231.00đ
WoS Q4(IF: 3.3)
🔵 Computed
20221.00đ
WoS Q4(IF: 3.784)
🔵 Computed
20211.00đ
WoS Q4(IF: 3.507)
🔵 Computed
20201.00đ
WoS Q4(IF: 3.024)
🔵 Computed
20191.00đ
WoS Q4(IF: 2.721)
🔵 Computed
20181.00đ
WoS Q4(IF: 2.387)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research. The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine. European Review for Medical and Pharmacological Sciences includes: -Editorials- Reviews- Original articles- Trials- Brief communications- Case reports (only if of particular interest and accompanied by a short review)

Topics Covered (Recognized by AI)
MedicineBiologyInternal MedicineGeneticsChemistryBiochemistryPathologySurgeryEndocrinologyImmunologyPsychologyCancer ResearchOncology & Cancer ResearchPsychiatryRadiologyCell Biology
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #31,883SCImago Profile
Scopus Coverage:1979-2025
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)
—

Weighted prestige citation metric per document indexed in the Scopus database.

Đã chuẩn hóa dữ liệu
Scopus H-Index (2025)
103

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
1.84

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,052 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations5,472
3-Year Documents2,918
Citable Documents2,875

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate36.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)—
Pharmacology (medical)—

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
In warning list
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Subscription
OA publishing option or traditional subscription
Publisher
Verduci Editore
Publication Language
English
Frequency
Bimonthly
Founding Year
1997
Editorial Address
VERDUCI PUBLISHER, VIA GREGORIO VII, ROME, ITALY, 186-00165
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

18 year
YearImpact FactorArticles / YearTotal Citations
20233.3——
20223.784——
20213.507——
20203.024——
20192.721——
20182.387——
2012—31
2010—11
1995—25
1994—24
1992—40
1991—10
1990—10
1989—20
1988—40
1987—15
1986—20
1985—30
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for European Review for Medical and Pharmacological Sciences

WoS Q1
12452018201920202021202220233.30
Annual Impact Factor Metric
2023:3.3

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 2d6671c1-3923-4edd-a7c3-ea7e61db6c8b
Database Updated: 2026-09-28